article thumbnail

Outsourcing Peptide Synthesis: Preferred Choice of Drug Developers

Roots Analysis

The peptide therapeutics market has undergone substantial evolution since the inception of insulin. As a result, many small drug developers and occasionally larger pharmaceutical companies prefer to outsource manufacturing to contract service providers.

article thumbnail

Sartorius Stedim Biotech to acquire Novasep’s chromatography process equipment division

The Pharma Data

Novasep’s chromatography unit comprises resin-based batch and intensified chromatography systems, and primarily focuses on high-pressure, multi-use applications for smaller molecules, such as oligonucleotides, peptides and insulin.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The challenges and trends of cell & gene therapies 

Drug Discovery World

Indeed, the growth of the cell and gene therapy market, coupled with the demand that the pandemic placed on manufacturing capacity, means the industry faces shortages of these crucial materials. The Skills Demand Survey Report presents a lack of graduate life sciences apprenticeship programmes as a key barrier.

article thumbnail

Sartorius to acquire Novasep’s chromatography process equipment division

The Pharma Data

6, 2021 /PRNewswire/ — The life science company Sartorius today announced it has entered into an agreement through its subgroup Sartorius Stedim Biotech to acquire the chromatography process equipment division of Novasep. Proposed transaction builds on both companies’ strategic R&D partnership.